MOTS-c is a mitochondrial-derived peptide that influences how cells use glucose and fat for energy, described as mimicking some of the metabolic effects of exercise at a cellular level, with reported benefits including increased stamina and reduced belly fat
Metabolic Pharmaceuticals terminated development for obesity in February 2007
Mechanistic Focus in Research Within experimental laboratory settings, 5-Amino-1MQ is commonly studied in relation to metabolic signalling pathways
No dose-ranging study has established a human oral dose for this compound, so the high oral numbers circulate as community and vendor convention rather than as published clinical figures
Its often used for people managing chronic fatigue, inflammation, or neuropathy
A reasonable candidate is someone who: Is already following a structured, clinician-supervised nutrition and activity plan Has a documented B12 deficiency or a condition that impairs B12 absorption Cannot tolerate GLP-1 medications, or is not a candidate for them Declines prescription pharmacotherapy and wants a non-stimulant, non-surgical adjunct Understands because the clinician has said so plainly that the injection is a supporting player A poor candidate is someone who wants the shot instead of the program
